Bio-Rad Laboratories

Bio-Rad Laboratories

Bio-Rad | Products for Life Science Research & Clinical Diagnostics.

  • Edit

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
USD2021202220232024202520262027
Revenues0000000000000000000000000000
% growth15 %(4 %)(5 %)(4 %)(2 %)3 %3 %
EBITDA0000000000000000000000000000
% EBITDA margin22 %24 %22 %20 %16 %17 %17 %
Profit0000000000000000000000000000
% profit margin145 %(129 %)(24 %)(72 %)7 %7 %7 %
EV0000000000000000000000000000
EV / revenue00.0x00.0x00.0x00.0x00.0x00.0x00.0x
EV / EBITDA00.0x00.0x00.0x00.0x00.0x00.0x00.0x
R&D budget0000000000000000000000000000
R&D % of revenue9 %9 %9 %12 %---

Source: Company filings or news article, Equity research estimates

More about Bio-Rad Laboratories
Made with AI
Edit

Bio-Rad Laboratories, Inc. is a global leader in developing, manufacturing, and marketing a broad range of innovative products for the life science research and clinical diagnostics markets. The company serves academic institutions, pharmaceutical companies, biotechnology firms, and clinical laboratories. Bio-Rad operates in the highly competitive life sciences and diagnostics markets, offering products that include reagents, instruments, and software for cell biology, gene expression, protein purification, and imaging. The business model focuses on selling these products directly to customers through a dedicated sales force and online platforms, generating revenue through product sales and service contracts. Bio-Rad's commitment to quality and innovation helps researchers and clinicians advance their discoveries and improve patient outcomes.

Keywords: life science research, clinical diagnostics, reagents, instruments, software, gene expression, protein purification, imaging, biotechnology, pharmaceutical.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo
Investments analysisEdit

Investments by Bio-Rad Laboratories

Edit
QuantaLife
ACQUISITION by Bio-Rad Laboratories Oct 2011
AbD Serotec
ACQUISITION by Bio-Rad Laboratories Jan 2013
Curiosity Diagnostics Sp z.o.o.
ACQUISITION by Bio-Rad Laboratories Aug 2022
OncoCyte
exited
GnuBIO
ACQUISITION by Bio-Rad Laboratories Apr 2014
Stilla Technologies
ACQUISITION by Bio-Rad Laboratories Feb 2025
DiaMed Holding AG
ACQUISITION by Bio-Rad Laboratories May 2007
Celsee
ACQUISITION by Bio-Rad Laboratories Apr 2020
View 1 more